← Open Payments lookup

NADYA MENDEZ: Open Payments

NPI 1871045112 · MISSION, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$707 in 25 payments from 10 companies in 2025. Trend: 2023 $1,032 · 2024 $995 · 2025 $707

Food & beverage: $707
CompanyPaymentsAmount
Lilly USA, LLC5$185
Novo Nordisk Inc8$183
AstraZeneca Pharmaceuticals LP3$178
Exact Sciences Corporation3$46
PFIZER INC.1$25
GlaxoSmithKline, LLC.1$23
Abbott Laboratories1$21
Xeris Pharmaceuticals, Inc.1$16
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$15
Amgen Inc.1$14

Products named: Ozempic, BREZTRI, ZEPBOUND, Cologuard Collection Kit, FARXIGA, JARDIANCE, MOUNJARO, PAXLOVID.

Industry payments across TX — which companies pay providers there.